Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | CYCN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,71 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 1,7501 - 5,25 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 2,71 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
7,34M | 2,71M | - | 0 | -5,26M | -1,94 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Cyclerion Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
07/5/2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
26/1/2024 | 22:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
11/12/2023 | 23:09 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
04/12/2023 | 23:09 | Edgar (US Regulatory) | Form 8-K - Current report |
04/12/2023 | 14:00 | GlobeNewswire Inc. | Cyclerion Appoints Regina Graul, Ph.D., as President |
01/12/2023 | 14:01 | Edgar (US Regulatory) | Form 8-K - Current report |
01/12/2023 | 00:16 | GlobeNewswire Inc. | Cyclerion Strengthens Board of Directors with Experienced.. |
24/11/2023 | 19:06 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2023 | 22:58 | Edgar (US Regulatory) | Form 8-K - Current report |
31/7/2023 | 13:00 | GlobeNewswire Inc. | Tisento Launches with $81 Million From Top-Tier Investor.. |
28/7/2023 | 22:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Cyclerion Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Cyclerion Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 2,90 | 3,0719 | 2,60 | 2,77 | 940 | -0,19 | -6,55% |
1 mois | 3,04 | 3,1999 | 2,60 | 2,88 | 862 | -0,33 | -10,86% |
3 mois | 3,10 | 3,98 | 2,60 | 3,12 | 2 142 | -0,39 | -12,58% |
6 mois | 2,15 | 5,25 | 1,7501 | 3,35 | 4 900 | 0,56 | 26,05% |
1 an | 4,91 | 5,25 | 1,7501 | 3,62 | 7 045 | -2,20 | -44,81% |
3 ans | 63,80 | 97,20 | 1,7501 | 46,80 | 255 860 | -61,09 | -95,75% |
5 ans | 303,00 | 311,20 | 1,7501 | 64,70 | 342 626 | -300,29 | -99,11% |